Article
ECJ Dismisses Astrazeneca Appeal Over Abusive Misuse Of Patent System And Regulatory Procedures Involving Anti-Ulcer Pharmaceutical Losec®
On 6 December 2012, the Court of Justice of the European Union handed down its judgment in the AstraZeneca case, following an appeal against a 2010 judgment of the General Court which itself had upheld in large part an earlier decision of the European Commission that had imposed a € 60 million fine on the company for abuse of the patent system and regulatory procedures in the pharmaceutical sector.
Van Bael & Bellis
